Last quarter (Q3 2024), Mural Oncology Plc's total revenue was $―, a decrease of ― from previous quarter. In Q3, Mural Oncology Plc's net income was $-31.76M. See Mural Oncology Plc’s key income statements, including revenue, expenses, profit, and income.
Income Statement
Dec 23
Total Revenue
-
Cost of Revenue
-
Gross Profit
-
Operating Expense
$ 196.24M
Operating Income
$ -196.24M
Net Non Operating Interest Income Expense
-
Other Income Expense
$ -951.00K
Pretax Income
$ -195.29M
Tax Provision
$ 12.16M
Earnings From Equity Interest Net Of Tax
-
Net Income Common Stockholders
$ -207.45M
Basic EPS
$ -12.43
Diluted EPS
$ -12.43
Basic Average Shares
$ 16.69M
Diluted Average Shares
$ 16.69M
Dividend Per Share
-
Total Operating Income As Reported
-
Reported Normalized Basic E P S
-
Reported Normalized Diluted E P S
-
Rent Expense Supplemental
-
Total Expenses
$ 196.24M
Net Income From Continuing And Discontinued Operation